Full course description
About this Course
CNE Information and Disclosures
Original Release: May 3, 2017
Expiration Date: January 13, 2023
This activity is designed to meet the educational needs of practicing nurses and advanced practice nurses.
Identify and manage individuals at increased risk of cancer due to familial factors and hereditary cancer syndromes.
CNE Approval Statement
This nursing continuing professional development activity was approved by the Northeast Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Claiming Your Credit
In order to claim credit 1) answer the pre-assessment questions, 2) work through the module content in its entirety, 3) successfully complete the post-assessment answering 2 out of 4 questions correctly and 4) complete the evaluation.
Nurses are eligible for a maximum of .25 contact hours upon the completion of this activity.
Planners, Writers, and Reviewers
- Hayley Dunnack, MS, RN, CMSRN, ONC – Hartford Hospital
- Emily Edelman, MS, CGC – The Jackson Laboratory
- Greg Feero, MD, PhD - Maine Dartmouth Family Medicine Residency
- Therese Ingram, MA – The Jackson Laboratory
- Aman Mann, MS, CGC – Northwell Health
- Kate Reed, MPH, ScM, CGC – The Jackson Laboratory
- Linda Steinmark, MS, CGC – The Jackson Laboratory
Conflict of Interest Disclosure
This educational activity does not include any content that relates to the products and/or services of a commercial interest that would create a conflict of interest. Unless otherwise noted, the program planners and faculty do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this course.
The following disclosures are reported that could be perceived as a real or apparent conflict of interest in the education program: Emily Edelman and Kate Reed received salary support from Pfizer Inc. through an unrestricted quality improvement grant that focuses on improving ascertainment of hereditary breast cancer, provided by the American Community Cancer Centers and Pfizer Independent Grants for Learning & Change. In their roles as planners and content authors, Ms. Edelman and Ms. Reed recused themselves from all deliberations relating to content related to the commercial entity with which they have financial interest and were not responsible for reviewing for bias any related content. All educational material has been peer-reviewed by external reviewers to assess for bias.
An earlier version of this program was supported by educational grants from The Maine Cancer Foundation and The Jackson Laboratory Director's Innovation Fund. There is no commercial support being received for this activity.
Audio speakers or headphones
Screen resolution of 800X600 or higher
Adobe Reader 5.0 or higher
For best performance in a mobile environment, please download the Canvas Mobile App for IOS and Android.
Should you have technical questions or questions regarding the content of the activity, please email Clinical and Continuing Education at the Jackson Laboratory.
All information in Cancer Genetic Clinical Education is provided for educational purposes only. This information is not a substitute for clinical guidance or the consultation of a medical professional. Always seek the advice of a qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in Cancer Genetic Clinical Education. Reliance on any information in Cancer Genetic Clinical Education is solely at your own risk. The Jackson Laboratory does not endorse or recommend any specific procedures, tests, products, services, health professionals or other information that may be found in Cancer Genetic Clinical Education.